{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:28:49Z","timestamp":1793755729095,"version":"4.6.1"},"reference-count":171,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:00:00Z","timestamp":1481068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/nrgastro.2016.168","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:03:33Z","timestamp":1481069013000},"page":"55-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":657,"title":["Liver \u2014 guardian, modifier and target of sepsis"],"prefix":"10.1038","volume":"14","author":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,7]]},"reference":[{"key":"BFnrgastro2016168_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M.  et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"BFnrgastro2016168_CR2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","volume":"146","author":"B Schnabl","year":"2014","unstructured":"Schnabl, B. & Brenner, D. A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146, 1513\u20131524 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","volume":"12","author":"U Protzer","year":"2012","unstructured":"Protzer, U., Maini, M. K. & Knolle, P. A. Living in the liver: hepatic infections. Nat. Rev. Immunol. 12, 201\u2013213 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrgastro2016168_CR4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","volume":"13","author":"F Heymann","year":"2016","unstructured":"Heymann, F. & Tacke, F. Immunology in the liver \u2014 from homeostasis to disease. Nat. Rev. Gastroenterol. Hepatol. 13, 88\u2013110 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016168_CR5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-309990","volume":"65","author":"JR Marchesi","year":"2016","unstructured":"Marchesi, J. R.  et al. The gut microbiota and host health: a new clinical frontier. Gut 65, 330\u2013339 (2016).","journal-title":"Gut"},{"key":"BFnrgastro2016168_CR6","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","volume":"60","author":"R Jalan","year":"2014","unstructured":"Jalan, R.  et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J. Hepatol. 60, 1310\u20131324 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/apt.12797","volume":"40","author":"AK Singal","year":"2014","unstructured":"Singal, A. K., Salameh, H. & Kamath, P. S. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States. Aliment. Pharmacol. Ther. 40, 105\u2013112 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016168_CR8","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/hep.25947","volume":"56","author":"JS Bajaj","year":"2012","unstructured":"Bajaj, J. S.  et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology 56, 2328\u20132335 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR9","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","volume":"14","author":"CN Jenne","year":"2013","unstructured":"Jenne, C. N. & Kubes, P. Immune surveillance by the liver. Nat. Immunol. 14, 996\u20131006 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016168_CR10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/his.12364","volume":"64","author":"EM Brunt","year":"2014","unstructured":"Brunt, E. M.  et al. Pathology of the liver sinusoids. Histopathology 64, 907\u2013920 (2014).","journal-title":"Histopathology"},{"key":"BFnrgastro2016168_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2014.12.020","volume":"42","author":"C Bleriot","year":"2015","unstructured":"Bleriot, C.  et al. Liver-resident macrophage necroptosis orchestrates type 1 microbicidal inflammation and type-2-mediated tissue repair during bacterial infection. Immunity 42, 145\u2013158 (2015).","journal-title":"Immunity"},{"key":"BFnrgastro2016168_CR12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428\u2013435 (2008).","journal-title":"Nature"},{"key":"BFnrgastro2016168_CR13","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00018-016-2206-1","volume":"73","author":"C Bleriot","year":"2016","unstructured":"Bleriot, C. & Lecuit, M. The interplay between regulated necrosis and bacterial infection. Cell. Mol. Life Sci. 73, 2369\u20132378 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrgastro2016168_CR14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","volume":"62","author":"F Heymann","year":"2015","unstructured":"Heymann, F.  et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 62, 279\u2013291 (2015).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/317537","volume":"32","author":"B Spellberg","year":"2001","unstructured":"Spellberg, B. & Edwards, J. E. Jr. Type 1\/type 2 immunity in infectious diseases. Clin. Infect. Dis. 32, 76\u2013102 (2001).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrgastro2016168_CR16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/08830185.2014.889129","volume":"33","author":"J Yan","year":"2014","unstructured":"Yan, J., Li, S. & Li, S. The role of the liver in sepsis. Int. Rev. Immunol. 33, 498\u2013510 (2014).","journal-title":"Int. Rev. Immunol."},{"key":"BFnrgastro2016168_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.chom.2012.06.011","volume":"12","author":"B McDonald","year":"2012","unstructured":"McDonald, B., Urrutia, R., Yipp, B. G., Jenne, C. N. & Kubes, P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12, 324\u2013333 (2012).","journal-title":"Cell Host Microbe"},{"key":"BFnrgastro2016168_CR18","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1038\/ncomms7673","volume":"6","author":"E Kolaczkowska","year":"2015","unstructured":"Kolaczkowska, E.  et al. Molecular mechanisms of NET formation and degradation revealed by intravital imaging in the liver vasculature. Nat. Commun. 6, 6673 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrgastro2016168_CR19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2013.01.005","volume":"13","author":"CN Jenne","year":"2013","unstructured":"Jenne, C. N.  et al. Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular traps. Cell Host Microbe 13, 169\u2013180 (2013).","journal-title":"Cell Host Microbe"},{"key":"BFnrgastro2016168_CR20","doi-asserted-by":"crossref","first-page":"e111888","DOI":"10.1371\/journal.pone.0111888","volume":"9","author":"K Tanaka","year":"2014","unstructured":"Tanaka, K.  et al. In vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model. PLoS ONE 9, e111888 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016168_CR21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mvr.2014.10.006","volume":"97","author":"Y Wu","year":"2015","unstructured":"Wu, Y.  et al. Laser speckle contrast imaging for measurement of hepatic microcirculation during the sepsis: a novel tool for early detection of microcirculation dysfunction. Microvasc. Res. 97, 137\u2013146 (2015).","journal-title":"Microvasc. Res."},{"key":"BFnrgastro2016168_CR22","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jhep.2013.12.005","volume":"60","author":"A Moles","year":"2014","unstructured":"Moles, A.  et al. A TLR2\/S100A9\/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse. J. Hepatol. 60, 782\u2013791 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI76887","volume":"125","author":"P Huebener","year":"2015","unstructured":"Huebener, P.  et al. The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J. Clin. Invest. 125, 539\u2013550 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016168_CR24","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ni.2921","volume":"15","author":"WM Nauseef","year":"2014","unstructured":"Nauseef, W. M. & Borregaard, N. Neutrophils at work. Nat. Immunol. 15, 602\u2013611 (2014).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016168_CR25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature15367","volume":"525","author":"D Zhang","year":"2015","unstructured":"Zhang, D.  et al. Neutrophil ageing is regulated by the microbiome. Nature 525, 528\u2013532 (2015).","journal-title":"Nature"},{"key":"BFnrgastro2016168_CR26","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.15252\/embj.201489055","volume":"33","author":"Z Abdullah","year":"2014","unstructured":"Abdullah, Z. & Knolle, P. A. Scaling of immune responses against intracellular bacterial infection. EMBO J. 33, 2283\u20132294 (2014).","journal-title":"EMBO J."},{"key":"BFnrgastro2016168_CR27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke, F. & Zimmermann, H. W. Macrophage heterogeneity in liver injury and fibrosis. J. Hepatol. 60, 1090\u20131096 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.2631","volume":"14","author":"CH Wong","year":"2013","unstructured":"Wong, C. H., Jenne, C. N., Petri, B., Chrobok, N. L. & Kubes, P. Nucleation of platelets with blood-borne pathogens on Kupffer cells precedes other innate immunity and contributes to bacterial clearance. Nat. Immunol. 14, 785\u2013792 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016168_CR29","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.3748\/wjg.v19.i23.3534","volume":"19","author":"G Tarantino","year":"2013","unstructured":"Tarantino, G., Scalera, A. & Finelli, C. Liver\u2013spleen axis: intersection between immunity, infections and metabolism. World J. Gastroenterol. 19, 3534\u20133542 (2013).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016168_CR30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1126\/science.1215173","volume":"335","author":"PJ Rauch","year":"2012","unstructured":"Rauch, P. J.  et al. Innate response activator B cells protect against microbial sepsis. Science 335, 597\u2013601 (2012).","journal-title":"Science"},{"key":"BFnrgastro2016168_CR31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","volume":"14","author":"LR Huang","year":"2013","unstructured":"Huang, L. R.  et al. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+ T cells and successful immunotherapy against chronic viral liver infection. Nat. Immunol. 14, 574\u2013583 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016168_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00430-014-0371-0","volume":"204","author":"PA Knolle","year":"2015","unstructured":"Knolle, P. A., Bottcher, J. & Huang, L. R. The role of hepatic immune regulation in systemic immunity to viral infection. Med. Microbiol. Immunol. 204, 21\u201327 (2015).","journal-title":"Med. Microbiol. Immunol."},{"key":"BFnrgastro2016168_CR33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MCC.0b013e32835eba6d","volume":"19","author":"M Bauer","year":"2013","unstructured":"Bauer, M., Press, A. T. & Trauner, M. The liver in sepsis: patterns of response and injury. Curr. Opin. Crit. Care 19, 123\u2013127 (2013).","journal-title":"Curr. Opin. Crit. Care"},{"key":"BFnrgastro2016168_CR34","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1097\/00003246-200212000-00016","volume":"30","author":"JP Cobb","year":"2002","unstructured":"Cobb, J. P.  et al. Sepsis gene expression profiling: murine splenic compared with hepatic responses determined by using complementary DNA microarrays. Crit. Care Med. 30, 2711\u20132721 (2002).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jss.2011.11.1031","volume":"176","author":"Q Yang","year":"2012","unstructured":"Yang, Q.  et al. Dynamics of hepatic gene expression profile in a rat cecal ligation and puncture model. J. Surg. Res. 176, 583\u2013600 (2012).","journal-title":"J. Surg. Res."},{"key":"BFnrgastro2016168_CR36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1164\/rccm.201404-0624OC","volume":"190","author":"RJ Langley","year":"2014","unstructured":"Langley, R. J.  et al. Integrative \u201comic\u201d analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am. J. Respir. Crit. Care Med. 190, 445\u2013455 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrgastro2016168_CR37","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/CCM.0000000000000131","volume":"42","author":"F Tacke","year":"2014","unstructured":"Tacke, F.  et al. Levels of circulating miR-133a are elevated in sepsis and predict mortality in critically ill patients. Crit. Care Med. 42, 1096\u20131104 (2014).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR38","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.3390\/ijms17010078","volume":"17","author":"F Benz","year":"2016","unstructured":"Benz, F., Roy, S., Trautwein, C., Roderburg, C. & Luedde, T. Circulating microRNAs as biomarkers for sepsis. Int. J. Mol. Sci. 17, E78 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrgastro2016168_CR39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fmicb.2012.00284","volume":"3","author":"S Lambeck","year":"2012","unstructured":"Lambeck, S., Weber, M., Gonnert, F. A., Mrowka, R. & Bauer, M. Comparison of sepsis-induced transcriptomic changes in a murine model to clinical blood samples identifies common response patterns. Front. Microbiol. 3, 284 (2012).","journal-title":"Front. Microbiol."},{"key":"BFnrgastro2016168_CR40","doi-asserted-by":"crossref","first-page":"e1001341","DOI":"10.1371\/journal.pmed.1001341","volume":"9","author":"JC Marshall","year":"2012","unstructured":"Marshall, J. C. New translational research provides insights into liver dysfunction in sepsis. PLoS Med. 9, e1001341 (2012).","journal-title":"PLoS Med."},{"key":"BFnrgastro2016168_CR41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ejcb.2011.09.008","volume":"91","author":"JG Bode","year":"2012","unstructured":"Bode, J. G., Albrecht, U., Haussinger, D., Heinrich, P. C. & Schaper, F. Hepatic acute phase proteins \u2014 regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-\u03baB-dependent signaling. Eur. J. Cell Biol. 91, 496\u2013505 (2012).","journal-title":"Eur. J. Cell Biol."},{"key":"BFnrgastro2016168_CR42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-008-8091-0","volume":"36","author":"F Tacke","year":"2009","unstructured":"Tacke, F., Luedde, T. & Trautwein, C. Inflammatory pathways in liver homeostasis and liver injury. Clin. Rev. Allergy Immunol. 36, 4\u201312 (2009).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"BFnrgastro2016168_CR43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448\u2013457 (2015).","journal-title":"Nat. Immunol."},{"key":"BFnrgastro2016168_CR44","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","volume":"108","author":"C Shah","year":"2006","unstructured":"Shah, C., Hari-Dass, R. & Raynes, J. G. Serum amyloid A is an innate immune opsonin for gram-negative bacteria. Blood 108, 1751\u20131757 (2006).","journal-title":"Blood"},{"key":"BFnrgastro2016168_CR45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","volume":"449","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov, R. Recognition of microorganisms and activation of the immune response. Nature 449, 819\u2013826 (2007).","journal-title":"Nature"},{"key":"BFnrgastro2016168_CR46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4049\/jimmunol.181.1.22","volume":"181","author":"N Cheng","year":"2008","unstructured":"Cheng, N., He, R., Tian, J., Ye, P. P. & Ye, R. D. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 181, 22\u201326 (2008).","journal-title":"J. Immunol."},{"key":"BFnrgastro2016168_CR47","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1111\/j.1582-4934.2009.00893.x","volume":"13","author":"PA Ward","year":"2009","unstructured":"Ward, P. A. & Gao, H. Sepsis, complement and the dysregulated inflammatory response. J. Cell. Mol. Med. 13, 4154\u20134160 (2009).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrgastro2016168_CR48","doi-asserted-by":"crossref","first-page":"124021","DOI":"10.1155\/2013\/124021","volume":"2013","author":"C Lelubre","year":"2013","unstructured":"Lelubre, C., Anselin, S., Zouaoui Boudjeltia, K., Biston, P. & Piagnerelli, M. Interpretation of C-reactive protein concentrations in critically ill patients. Biomed. Res. Int. 2013, 124021 (2013).","journal-title":"Biomed. Res. Int."},{"key":"BFnrgastro2016168_CR49","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1749-6632.2001.tb03523.x","volume":"936","author":"TP Ugarova","year":"2001","unstructured":"Ugarova, T. P. & Yakubenko, V. P. Recognition of fibrinogen by leukocyte integrins. Ann. N. Y. Acad. Sci. 936, 368\u2013385 (2001).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFnrgastro2016168_CR50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.moh.0000131440.02397.a4","volume":"11","author":"DH Farrell","year":"2004","unstructured":"Farrell, D. H. Pathophysiologic roles of the fibrinogen gamma chain. Curr. Opin. Hematol. 11, 151\u2013155 (2004).","journal-title":"Curr. Opin. Hematol."},{"key":"BFnrgastro2016168_CR51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448\u2013454 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016168_CR52","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","volume":"207","author":"LE Sander","year":"2010","unstructured":"Sander, L. E.  et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453\u20131464 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2016168_CR53","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.21837","volume":"46","author":"R Sakamori","year":"2007","unstructured":"Sakamori, R.  et al. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 46, 1564\u20131573 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1053\/j.gastro.2006.10.018","volume":"132","author":"A Pietrangelo","year":"2007","unstructured":"Pietrangelo, A.  et al. STAT3 is required for IL-6-gp130\u2013dependent activation of hepcidin in vivo. Gastroenterology 132, 294\u2013300 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR55","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","volume":"110","author":"G Nicolas","year":"2002","unstructured":"Nicolas, G.  et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037\u20131044 (2002).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016168_CR56","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1224577","volume":"338","author":"H Drakesmith","year":"2012","unstructured":"Drakesmith, H. & Prentice, A. M. Hepcidin and the iron-infection axis. Science 338, 768\u2013772 (2012).","journal-title":"Science"},{"key":"BFnrgastro2016168_CR57","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/ALN.0000000000000466","volume":"122","author":"C Zeng","year":"2015","unstructured":"Zeng, C.  et al. Hepatic hepcidin protects against polymicrobial sepsis in mice by regulating host iron status. Anesthesiology 122, 374\u2013386 (2015).","journal-title":"Anesthesiology"},{"key":"BFnrgastro2016168_CR58","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.chom.2014.12.001","volume":"17","author":"J Arezes","year":"2015","unstructured":"Arezes, J.  et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47\u201357 (2015).","journal-title":"Cell Host Microbe"},{"key":"BFnrgastro2016168_CR59","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/CCM.0000000000001607","volume":"44","author":"F Tacke","year":"2016","unstructured":"Tacke, F.  et al. Iron parameters determine the prognosis of critically ill patients. Crit. Care Med. 44, 1049\u20131058 (2016).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellimm.2012.08.005","volume":"279","author":"D Ren","year":"2012","unstructured":"Ren, D.  et al. Myeloid-derived suppressor cells accumulate in the liver site after sepsis to induce immunosuppression. Cell. Immunol. 279, 12\u201320 (2012).","journal-title":"Cell. Immunol."},{"key":"BFnrgastro2016168_CR61","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4291\/wjgp.v6.i3.43","volume":"6","author":"L Hammerich","year":"2015","unstructured":"Hammerich, L. & Tacke, F. Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis. World J. Gastrointest. Pathophysiol. 6, 43\u201350 (2015).","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"BFnrgastro2016168_CR62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/cc13110","volume":"17","author":"E Lopez-Collazo","year":"2013","unstructured":"Lopez-Collazo, E. & del Fresno, C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit. Care 17, 242 (2013).","journal-title":"Crit. Care"},{"key":"BFnrgastro2016168_CR63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00011-011-0342-5","volume":"60","author":"DW Shi","year":"2011","unstructured":"Shi, D. W.  et al. LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis. Inflamm. Res. 60, 841\u2013849 (2011).","journal-title":"Inflamm. Res."},{"key":"BFnrgastro2016168_CR64","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.2174\/092986706778201675","volume":"13","author":"A Broad","year":"2006","unstructured":"Broad, A., Jones, D. E. & Kirby, J. A. Toll-like receptor (TLR) response tolerance: a key physiological \u201cdamage limitation\u201d effect and an important potential opportunity for therapy. Curr. Med. Chem. 13, 2487\u20132502 (2006).","journal-title":"Curr. Med. Chem."},{"key":"BFnrgastro2016168_CR65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1615\/CritRevImmunol.2015015495","volume":"35","author":"PE Collins","year":"2015","unstructured":"Collins, P. E. & Carmody, R. J. The regulation of endotoxin tolerance and its impact on macrophage activation. Crit. Rev. Immunol. 35, 293\u2013323 (2015).","journal-title":"Crit. Rev. Immunol."},{"key":"BFnrgastro2016168_CR66","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.22839","volume":"49","author":"MJ Scott","year":"2009","unstructured":"Scott, M. J., Liu, S., Shapiro, R. A., Vodovotz, Y. & Billiar, T. R. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology 49, 1695\u20131708 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR67","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1189\/jlb.0604332","volume":"77","author":"A Uhrig","year":"2005","unstructured":"Uhrig, A.  et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J. Leukoc. Biol. 77, 626\u2013633 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrgastro2016168_CR68","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.4049\/jimmunol.1102460","volume":"188","author":"A Dangi","year":"2012","unstructured":"Dangi, A.  et al. Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J. Immunol. 188, 3667\u20133677 (2012).","journal-title":"J. Immunol."},{"key":"BFnrgastro2016168_CR69","doi-asserted-by":"crossref","first-page":"e0144278","DOI":"10.1371\/journal.pone.0144278","volume":"10","author":"S Dizier","year":"2015","unstructured":"Dizier, S.  et al. Early hepatic dysfunction is associated with a worse outcome in patients presenting with acute respiratory distress syndrome: a post-hoc analysis of the ACURASYS and PROSEVA studies. PLoS ONE 10, e0144278 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016168_CR70","doi-asserted-by":"crossref","first-page":"R266","DOI":"10.1186\/cc10543","volume":"15","author":"A Koch","year":"2011","unstructured":"Koch, A.  et al. Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU. Crit. Care 15, R266 (2011).","journal-title":"Crit. Care"},{"key":"BFnrgastro2016168_CR71","doi-asserted-by":"crossref","first-page":"e1001338","DOI":"10.1371\/journal.pmed.1001338","volume":"9","author":"P Recknagel","year":"2012","unstructured":"Recknagel, P.  et al. Liver dysfunction and phosphatidylinositol\u20133-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med. 9, e1001338 (2012).","journal-title":"PLoS Med."},{"key":"BFnrgastro2016168_CR72","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent, J. L.  et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707\u2013710 (1996).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2016168_CR73","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1097\/ALN.0b013e318266c6df","volume":"117","author":"T Lescot","year":"2012","unstructured":"Lescot, T., Karvellas, C., Beaussier, M. & Magder, S. Acquired liver injury in the intensive care unit. Anesthesiology 117, 898\u2013904 (2012).","journal-title":"Anesthesiology"},{"key":"BFnrgastro2016168_CR74","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ar.20646","volume":"291","author":"H Spapen","year":"2008","unstructured":"Spapen, H. Liver perfusion in sepsis, septic shock, and multiorgan failure. Anat. Rec. (Hoboken) 291, 714\u2013720 (2008).","journal-title":"Anat. Rec. (Hoboken)"},{"key":"BFnrgastro2016168_CR75","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.jhep.2014.07.014","volume":"61","author":"V La Mura","year":"2014","unstructured":"La Mura, V.  et al. Liver sinusoidal endothelial dysfunction after LPS administration: a role for inducible-nitric oxide synthase. J. Hepatol. 61, 1321\u20131327 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR76","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","volume":"82","author":"J Henrion","year":"2003","unstructured":"Henrion, J.  et al. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 82, 392\u2013406 (2003).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016168_CR77","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2169\/internalmedicine.46.0059","volume":"46","author":"R Birrer","year":"2007","unstructured":"Birrer, R., Takuda, Y. & Takara, T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern. Med. 46, 1063\u20131070 (2007).","journal-title":"Intern. Med."},{"key":"BFnrgastro2016168_CR78","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/01.CCM.0000259462.97164.A0","volume":"35","author":"L Kramer","year":"2007","unstructured":"Kramer, L.  et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients \u2014 a prospective multicenter study. Crit. Care Med. 35, 1099\u20131104 (2007).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR79","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00134-009-1508-2","volume":"35","author":"V Fuhrmann","year":"2009","unstructured":"Fuhrmann, V.  et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 35, 1397\u20131405 (2009).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2016168_CR80","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/hep.25896","volume":"56","author":"B Jager","year":"2012","unstructured":"Jager, B.  et al. Jaundice increases the rate of complications and one-year mortality in patients with hypoxic hepatitis. Hepatology 56, 2297\u20132304 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR81","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/liv.12627","volume":"35","author":"C Roderburg","year":"2015","unstructured":"Roderburg, C.  et al. Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases. Liver Int. 35, 1172\u20131184 (2015).","journal-title":"Liver Int."},{"key":"BFnrgastro2016168_CR82","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.28493","volume":"64","author":"NO Ku","year":"2016","unstructured":"Ku, N. O., Strnad, P., Bantel, H. & Bishr Omary, M. Keratins: biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology 64, 966\u2013976 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2165\/11598610-000000000-00000","volume":"32","author":"DJ Moore","year":"2012","unstructured":"Moore, D. J.  et al. A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients. Clin. Drug Investig. 32, 179\u2013187 (2012).","journal-title":"Clin. Drug Investig."},{"key":"BFnrgastro2016168_CR84","doi-asserted-by":"crossref","first-page":"e109618","DOI":"10.1371\/journal.pone.0109618","volume":"9","author":"L Lorente","year":"2014","unstructured":"Lorente, L.  et al. Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study. PLoS ONE 9, e109618 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2016168_CR85","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00134-013-2926-8","volume":"39","author":"A Drolz","year":"2013","unstructured":"Drolz, A.  et al. Clinical impact of arterial ammonia levels in ICU patients with different liver diseases. Intensive Care Med. 39, 1227\u20131237 (2013).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2016168_CR86","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2741\/E598","volume":"5","author":"HK Bhogal","year":"2013","unstructured":"Bhogal, H. K. & Sanyal, A. J. The molecular pathogenesis of cholestasis in sepsis. Front. Biosci. (Elite Ed.) 5, 87\u201396 (2013).","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"BFnrgastro2016168_CR87","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ncpgasthep0602","volume":"3","author":"A Geier","year":"2006","unstructured":"Geier, A., Fickert, P. & Trauner, M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 574\u2013585 (2006).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016168_CR88","doi-asserted-by":"crossref","first-page":"G831","DOI":"10.1152\/ajpgi.00307.2004","volume":"289","author":"A Geier","year":"2005","unstructured":"Geier, A.  et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G831\u2013G841 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2016168_CR89","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1172\/JCI1680","volume":"101","author":"M Trauner","year":"1998","unstructured":"Trauner, M., Arrese, M., Lee, H., Boyer, J. L. & Karpen, S. J. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J. Clin. Invest. 101, 2092\u20132100 (1998).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro2016168_CR90","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00024382-200014020-00017","volume":"14","author":"PK Kim","year":"2000","unstructured":"Kim, P. K., Chen, J., Andrejko, K. M. & Deutschman, C. S. Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock 14, 176\u2013181 (2000).","journal-title":"Shock"},{"key":"BFnrgastro2016168_CR91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0030-1253227","volume":"30","author":"A Kosters","year":"2010","unstructured":"Kosters, A. & Karpen, S. J. The role of inflammation in cholestasis: clinical and basic aspects. Semin. Liver Dis. 30, 186\u2013194 (2010).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2016168_CR92","doi-asserted-by":"crossref","first-page":"G1008","DOI":"10.1152\/ajpgi.00071.2004","volume":"287","author":"MG Elferink","year":"2004","unstructured":"Elferink, M. G.  et al. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G1008\u2013G1016 (2004).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2016168_CR93","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-2000-9386","volume":"20","author":"D Haussinger","year":"2000","unstructured":"Haussinger, D., Schmitt, M., Weiergraber, O. & Kubitz, R. Short-term regulation of canalicular transport. Semin. Liver Dis. 20, 307\u2013321 (2000).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2016168_CR94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00024382-200014010-00010","volume":"14","author":"A De Maio","year":"2000","unstructured":"De Maio, A., Gingalewski, C., Theodorakis, N. G. & Clemens, M. G. Interruption of hepatic gap junctional communication in the rat during inflammation induced by bacterial lipopolysaccharide. Shock 14, 53\u201359 (2000).","journal-title":"Shock"},{"key":"BFnrgastro2016168_CR95","doi-asserted-by":"crossref","first-page":"G126","DOI":"10.1152\/ajpgi.00231.2003","volume":"286","author":"X Han","year":"2004","unstructured":"Han, X., Fink, M. P., Uchiyama, T., Yang, R. & Delude, R. L. Increased iNOS activity is essential for hepatic epithelial tight junction dysfunction in endotoxemic mice. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G126\u2013G136 (2004).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro2016168_CR96","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/01.mcg.0000155549.29643.ad","volume":"39","author":"M Strazzabosco","year":"2005","unstructured":"Strazzabosco, M., Fabris, L. & Spirli, C. Pathophysiology of cholangiopathies. J. Clin. Gastroenterol. 39, S90\u2013S102 (2005).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2016168_CR97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/gast.2001.25516","volume":"121","author":"C Spirli","year":"2001","unstructured":"Spirli, C.  et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology 121, 156\u2013169 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR98","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1210\/jc.2008-2579","volume":"94","author":"D Mesotten","year":"2009","unstructured":"Mesotten, D.  et al. The effect of strict blood glucose control on biliary sludge and cholestasis in critically ill patients. J. Clin. Endocrinol. Metab. 94, 2345\u20132352 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrgastro2016168_CR99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00134-005-0023-3","volume":"32","author":"N Brienza","year":"2006","unstructured":"Brienza, N.  et al. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med. 32, 267\u2013274 (2006).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2016168_CR100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/gut.48.3.409","volume":"48","author":"MW Whitehead","year":"2001","unstructured":"Whitehead, M. W., Hainsworth, I. & Kingham, J. G. The causes of obvious jaundice in south west Wales: perceptions versus reality. Gut 48, 409\u2013413 (2001).","journal-title":"Gut"},{"key":"BFnrgastro2016168_CR101","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.21480","volume":"45","author":"N Chand","year":"2007","unstructured":"Chand, N. & Sanyal, A. J. Sepsis-induced cholestasis. Hepatology 45, 230\u2013241 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR102","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gie.2012.10.008","volume":"77","author":"M Berzosa","year":"2013","unstructured":"Berzosa, M.  et al. Diagnostic bedside EUS in the intensive care unit: a single-center experience. Gastrointest. Endosc. 77, 200\u2013208 (2013).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2016168_CR103","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MCC.0b013e32835ec9e6","volume":"19","author":"T Horvatits","year":"2013","unstructured":"Horvatits, T., Trauner, M. & Fuhrmann, V. Hypoxic liver injury and cholestasis in critically ill patients. Curr. Opin. Crit. Care 19, 128\u2013132 (2013).","journal-title":"Curr. Opin. Crit. Care"},{"key":"BFnrgastro2016168_CR104","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000324141","volume":"29","author":"M Trauner","year":"2011","unstructured":"Trauner, M.  et al. Targeting nuclear bile acid receptors for liver disease. Dig. Dis. 29, 98\u2013102 (2011).","journal-title":"Dig. Dis."},{"key":"BFnrgastro2016168_CR105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim, T. Q., Tarling, E. J. & Edwards, P. A. Pleiotropic roles of bile acids in metabolism. Cell Metab. 17, 657\u2013669 (2013).","journal-title":"Cell Metab."},{"key":"BFnrgastro2016168_CR106","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2015.08.001","volume":"63","author":"HX Liu","year":"2015","unstructured":"Liu, H. X., Keane, R., Sheng, L. & Wan, Y. J. Implications of microbiota and bile acid in liver injury and regeneration. J. Hepatol. 63, 1502\u20131510 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR107","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765\u2013783.e4 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR108","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13054-015-0861-5","volume":"19","author":"S Leonhardt","year":"2015","unstructured":"Leonhardt, S.  et al. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Crit. Care 19, 131 (2015).","journal-title":"Crit. Care"},{"key":"BFnrgastro2016168_CR109","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2015.01.013","volume":"70","author":"T Voigtlander","year":"2015","unstructured":"Voigtlander, T.  et al. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis. J. Infect. 70, 483\u2013490 (2015).","journal-title":"J. Infect."},{"key":"BFnrgastro2016168_CR110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-967024","volume":"40","author":"H Kulaksiz","year":"2008","unstructured":"Kulaksiz, H., Heuberger, D., Engler, S. & Stiehl, A. Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40, 214\u2013218 (2008).","journal-title":"Endoscopy"},{"key":"BFnrgastro2016168_CR111","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","volume":"41","author":"RP Dellinger","year":"2013","unstructured":"Dellinger, R. P.  et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit. Care Med. 41, 580\u2013637 (2013).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR112","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"PT O'Gara","year":"2013","unstructured":"O'Gara, P. T.  et al. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation 127, 529\u2013555 (2013).","journal-title":"Circulation"},{"key":"BFnrgastro2016168_CR113","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/CCM.0B013E31816532BE","volume":"36","author":"C Aninat","year":"2008","unstructured":"Aninat, C.  et al. Catecholamines induce an inflammatory response in human hepatocytes. Crit. Care Med. 36, 848\u2013854 (2008).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR114","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.CCM.0000063045.77339.B6","volume":"31","author":"D De Backer","year":"2003","unstructured":"De Backer, D., Creteur, J., Silva, E. & Vincent, J. L. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit. Care Med. 31, 1659\u20131667 (2003).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jhep.2009.12.008","volume":"52","author":"P Taura","year":"2010","unstructured":"Taura, P.  et al. The use of \u03b2-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resection. J. Hepatol. 52, 340\u2013347 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR116","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hep.24755","volume":"55","author":"L Russo","year":"2012","unstructured":"Russo, L.  et al. Addition of simvastatin to cold storage solution prevents endothelial dysfunction in explanted rat livers. Hepatology 55, 921\u2013930 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR117","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jhep.2010.08.031","volume":"54","author":"L Llacuna","year":"2011","unstructured":"Llacuna, L.  et al. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. J. Hepatol. 54, 1002\u20131010 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR118","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jhep.2014.01.019","volume":"60","author":"A Drolz","year":"2014","unstructured":"Drolz, A.  et al. Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients. J. Hepatol. 60, 1187\u20131193 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR119","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0016-5085(99)70138-1","volume":"116","author":"R Kubitz","year":"1999","unstructured":"Kubitz, R., Wettstein, M., Warskulat, U. & Haussinger, D. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116, 401\u2013410 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung, C. L.  et al. Hydrocortisone therapy for patients with septic shock. N. Engl. J. Med. 358, 111\u2013124 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016168_CR121","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00134-011-2334-x","volume":"37","author":"R Moreno","year":"2011","unstructured":"Moreno, R.  et al. Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med. 37, 1765\u20131772 (2011).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2016168_CR122","first-page":"46","volume":"11","author":"S Finfer","year":"2009","unstructured":"Finfer, S., Heritier, S. & NICE Study Managament Committee and SUGAR Study Executive Committee. The NICE-SUGAR (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation) Study: statistical analysis plan. Crit. Care Resusc. 11, 46\u201357 (2009).","journal-title":"Crit. Care Resusc."},{"key":"BFnrgastro2016168_CR123","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clnu.2006.01.021","volume":"25","author":"KG Kreymann","year":"2006","unstructured":"Kreymann, K. G.  et al. ESPEN guidelines on enteral nutrition: intensive care. Clin. Nutr. 25, 210\u2013223 (2006).","journal-title":"Clin. Nutr."},{"key":"BFnrgastro2016168_CR124","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00003246-200102000-00003","volume":"29","author":"M Braga","year":"2001","unstructured":"Braga, M.  et al. Early postoperative enteral nutrition improves gut oxygenation and reduces costs compared with total parenteral nutrition. Crit. Care Med. 29, 242\u2013248 (2001).","journal-title":"Crit. Care Med."},{"key":"BFnrgastro2016168_CR125","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3748\/wjg.v9.i4.843","volume":"9","author":"QG Hu","year":"2003","unstructured":"Hu, Q. G. & Zheng, Q. C. The influence of enteral nutrition in postoperative patients with poor liver function. World J. Gastroenterol. 9, 843\u2013846 (2003).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016168_CR126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00075197-200503000-00013","volume":"8","author":"N Paquot","year":"2005","unstructured":"Paquot, N. & Delwaide, J. Fatty liver in the intensive care unit. Curr. Opin. Clin. Nutr. Metab. Care 8, 183\u2013187 (2005).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"BFnrgastro2016168_CR127","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","volume":"64","author":"FS Larsen","year":"2016","unstructured":"Larsen, F. S.  et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J. Hepatol. 64, 69\u201378 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhep.2015.09.010","volume":"64","author":"CJ Karvellas","year":"2016","unstructured":"Karvellas, C. J. & Stravitz, R. T. High volume plasma exchange in acute liver failure: dampening the inflammatory cascade? J. Hepatol. 64, 10\u201312 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2014.03.021","volume":"61","author":"M Bartoletti","year":"2014","unstructured":"Bartoletti, M.  et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J. Hepatol. 61, 51\u201358 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","volume":"60","author":"R Wiest","year":"2014","unstructured":"Wiest, R., Lawson, M. & Geuking, M. Pathological bacterial translocation in liver cirrhosis. J. Hepatol. 60, 197\u2013209 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR131","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/ajg.2015.313","volume":"110","author":"J Macnaughtan","year":"2015","unstructured":"Macnaughtan, J. & Jalan, R. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis. Am. J. Gastroenterol. 110, 1399\u20131410 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016168_CR132","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3748\/wjg.v20.i10.2542","volume":"20","author":"T Bruns","year":"2014","unstructured":"Bruns, T., Zimmermann, H. W. & Stallmach, A. Risk factors and outcome of bacterial infections in cirrhosis. World J. Gastroenterol. 20, 2542\u20132554 (2014).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2016168_CR133","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.42.1.29","volume":"42","author":"CJ O'Boyle","year":"1998","unstructured":"O'Boyle, C. J.  et al. Microbiology of bacterial translocation in humans. Gut 42, 29\u201335 (1998).","journal-title":"Gut"},{"key":"BFnrgastro2016168_CR134","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)00013-1","volume":"34","author":"I Cirera","year":"2001","unstructured":"Cirera, I.  et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J. Hepatol. 34, 32\u201337 (2001).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR135","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.23440","volume":"51","author":"B Appenrodt","year":"2010","unstructured":"Appenrodt, B.  et al. Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis. Hepatology 51, 1327\u20131333 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR136","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2011.02.022","volume":"55","author":"HD Nischalke","year":"2011","unstructured":"Nischalke, H. D.  et al. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J. Hepatol. 55, 1010\u20131016 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR137","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/liv.12625","volume":"35","author":"K Sargenti","year":"2015","unstructured":"Sargenti, K., Prytz, H., Strand, A., Nilsson, E. & Kalaitzakis, E. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome. Liver Int. 35, 391\u2013400 (2015).","journal-title":"Liver Int."},{"key":"BFnrgastro2016168_CR138","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/jhep.2002.30082","volume":"35","author":"J Fernandez","year":"2002","unstructured":"Fernandez, J.  et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35, 140\u2013148 (2002).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR139","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2011.11.023","volume":"56","author":"G Pereira","year":"2012","unstructured":"Pereira, G.  et al. Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study. J. Hepatol. 56, 1040\u20131046 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR140","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/hep.25931","volume":"56","author":"YM Arabi","year":"2012","unstructured":"Arabi, Y. M.  et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology 56, 2305\u20132315 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR141","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau, R.  et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 144, 1426\u20131437.e9 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR142","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1053\/j.gastro.2010.06.019","volume":"139","author":"V Arvaniti","year":"2010","unstructured":"Arvaniti, V.  et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 139, 1246\u20131256.e5 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR143","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.28332","volume":"63","author":"M Merli","year":"2016","unstructured":"Merli, M.  et al. An empirical broad spectrum antibiotic therapy in healthcare-associated infections improves survival in cirrhotics: a randomized trial. Hepatology 63, 1632\u20131639 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR144","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","volume":"63","author":"S Piano","year":"2016","unstructured":"Piano, S.  et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology 63, 1299\u20131309 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR145","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi, M., Moreau, R., Angeli, P., Schnabl, B. & Arroyo, V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J. Hepatol. 63, 1272\u20131284 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR146","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","volume":"59","author":"R Barreto","year":"2014","unstructured":"Barreto, R.  et al. Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival. Hepatology 59, 1505\u20131513 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR147","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12072-015-9641-1","volume":"10","author":"P Angeli","year":"2016","unstructured":"Angeli, P., Tonon, M., Pilutti, C., Morando, F. & Piano, S. Sepsis-induced acute kidney injury in patients with cirrhosis. Hepatol. Int. 10, 115\u2013123 (2016).","journal-title":"Hepatol. Int."},{"key":"BFnrgastro2016168_CR148","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc11381","volume":"16","author":"N Nesseler","year":"2012","unstructured":"Nesseler, N.  et al. Clinical review: the liver in sepsis. Crit. Care 16, 235 (2012).","journal-title":"Crit. Care"},{"key":"BFnrgastro2016168_CR149","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.1214935","volume":"335","author":"R Medzhitov","year":"2012","unstructured":"Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936\u2013941 (2012).","journal-title":"Science"},{"key":"BFnrgastro2016168_CR150","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","volume":"46","author":"D Thabut","year":"2007","unstructured":"Thabut, D.  et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 46, 1872\u20131882 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR151","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","volume":"133","author":"J Fernandez","year":"2007","unstructured":"Fernandez, J.  et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133, 818\u2013824 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR152","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ajg.2009.3","volume":"104","author":"S Saab","year":"2009","unstructured":"Saab, S., Hernandez, J. C., Chi, A. C. & Tong, M. J. Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am. J. Gastroenterol. 104, 993\u20131001 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016168_CR153","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","volume":"12","author":"P Gines","year":"1990","unstructured":"Gines, P.  et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12, 716\u2013724 (1990).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR154","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis, R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J. Hepatol. 63, 743\u2013752 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR155","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/gutjnl-2015-309262","volume":"64","author":"D Tripathi","year":"2015","unstructured":"Tripathi, D.  et al. U. K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 64, 1680\u20131704 (2015).","journal-title":"Gut"},{"key":"BFnrgastro2016168_CR156","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","volume":"131","author":"J Fernandez","year":"2006","unstructured":"Fernandez, J.  et al. Norfloxacin versus ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology 131, 1049\u20131056 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR157","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.28330","volume":"63","author":"J Fernandez","year":"2016","unstructured":"Fernandez, J., Tandon, P., Mensa, J. & Garcia-Tsao, G. Antibiotic prophylaxis in cirrhosis: good and bad. Hepatology 63, 2019\u20132031 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016168_CR158","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/apt.13135","volume":"41","author":"CJ Karvellas","year":"2015","unstructured":"Karvellas, C. J., Abraldes, J. G., Arabi, Y. M. & Kumar, A. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment. Pharmacol. Ther. 41, 747\u2013757 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016168_CR159","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1586\/17474124.2015.1100075","volume":"9","author":"J Fernandez","year":"2015","unstructured":"Fernandez, J. & Acevedo, J. New antibiotic strategies in patients with cirrhosis and bacterial infection. Expert Rev. Gastroenterol. Hepatol. 9, 1495\u20131500 (2015).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016168_CR160","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort, P.  et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403\u2013409 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016168_CR161","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","volume":"32","author":"A Rimola","year":"2000","unstructured":"Rimola, A.  et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J. Hepatol. 32, 142\u2013153 (2000).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR162","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","volume":"57","author":"M Guevara","year":"2012","unstructured":"Guevara, M.  et al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J. Hepatol. 57, 759\u2013765 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR163","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","volume":"62","author":"T Thevenot","year":"2015","unstructured":"Thevenot, T.  et al. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial. J. Hepatol. 62, 822\u2013830 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR164","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","volume":"64","author":"JA Leithead","year":"2015","unstructured":"Leithead, J. A.  et al. Non-selective \u03b2-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut 64, 1111\u20131119 (2015).","journal-title":"Gut"},{"key":"BFnrgastro2016168_CR165","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","volume":"146","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer, M.  et al. Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology 146, 1680\u20131690.e1 (2014).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR166","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","volume":"58","author":"T Reiberger","year":"2013","unstructured":"Reiberger, T.  et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J. Hepatol. 58, 911\u2013921 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR167","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","volume":"62","author":"T Reiberger","year":"2013","unstructured":"Reiberger, T.  et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 62, 1634\u20131641 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2016168_CR168","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","volume":"64","author":"RP Mookerjee","year":"2016","unstructured":"Mookerjee, R. P.  et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J. Hepatol. 64, 574\u2013582 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR169","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","volume":"150","author":"TD Boyer","year":"2016","unstructured":"Boyer, T. D.  et al. Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1. Gastroenterology 150, 1579\u20131589.e2 (2016).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016168_CR170","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","volume":"60","author":"E Rodriguez","year":"2014","unstructured":"Rodriguez, E.  et al. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. J. Hepatol. 60, 955\u2013961 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016168_CR171","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","volume":"148","author":"CK Kedarisetty","year":"2015","unstructured":"Kedarisetty, C. K.  et al. Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis. Gastroenterology 148, 1362\u20131370.e7 (2015).","journal-title":"Gastroenterology"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.168","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.168.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:14:29Z","timestamp":1733940869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,7]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFnrgastro2016168"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.168","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,7]]},"assertion":[{"value":"7 December 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}